Ownership and insider activity for iSpecimen Inc. (ISPC): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, bioba...
Price
| Price | $1.37 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2025-11-07 | Lee Arphing | |||
| 2024-12-13 | Liang Yuying | |||
| 2024-12-09 | LIM ROBERT BRADLEY | |||
| 2024-09-25 | Dhaliwal Avtar | A-Award | 168 | $860 |
| 2024-09-25 | Dhaliwal Avtar | |||
| 2024-09-25 | Paolone Richard | A-Award | 168 | $860 |
| 2024-09-25 | Field Katharyn | A-Award | 168 | $860 |
| 2024-09-25 | Paolone Richard | |||
| 2024-09-25 | Field Katharyn | |||
| 2024-01-02 | Ross Andrew L. | A-Award | 10,000 | $5K |
Balance Sheet (10y)
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.1M | $53893 | $695909 | $27.7M | $15.3M | $2.3M | $1.9M | $6.9M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | $2.7M | 0 | 0 |
| Receivables | $1.0M | $1.4M | $2.4M | $4.9M | $3.9M | $2.9M | $1.4M | $48298 |
| Inventory | $47287 | $54908 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $2.3M | $1.6M | $3.5M | $32.9M | $19.7M | $8.2M | $3.6M | $7.0M |
| Property, Plant & Equipment | $149098 | $119921 | $75589 | $32781 | $410544 | $321644 | $421540 | $294703 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $1.4M | $2.3M | $2.6M | $2.7M | $4.5M | $7.2M | $5.3M | $1.0M |
| Total Assets | $4.0M | $4.2M | $6.2M | $35.7M | $24.6M | $15.8M | $9.4M | $9.5M |
| Accounts Payable | $696912 | $737794 | $1.8M | $832678 | $2.5M | $3.9M | $4.2M | $5.4M |
| Short-term Debt | $7.0M | $10.6M | $12.6M | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $11.3M | $15.8M | $22.1M | $2.5M | $4.3M | $6.0M | $5.8M | $6.2M |
| Long-term Debt | 0 | 0 | $178899 | $3.4M | 0 | 0 | 0 | 0 |
| Total Liabilities | $22.5M | $26.9M | $33.5M | $5.9M | $4.3M | $6.1M | $6.0M | $6.4M |
| Retained Earnings | -$19.7M | -$24.4M | -$29.1M | -$38.0M | -$48.3M | -$59.4M | -$71.9M | -$82.4M |
| Total Equity | -$18.4M | -$22.7M | -$27.3M | $29.8M | $20.3M | $9.7M | $3.3M | $3.1M |
| Total Debt | $7.0M | $10.6M | $12.8M | $3.4M | $185847 | $196244 | $312167 | $268798 |
| Net Debt | $5.8M | $10.5M | $12.1M | -$24.3M | -$15.1M | -$4.8M | -$1.6M | -$6.6M |
| Working Capital | -$9.0M | -$14.2M | -$18.7M | $30.4M | $15.4M | $2.2M | -$2.2M | $723284 |
Financial Health
| Debt / Equity | 0.14 |
| Current Ratio | 0.82 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -14.80 |
Profitability
| Return on Equity | -524.37% |
| Return on Invested Capital | -476.39% |
| Return on Assets | -154.47% |
| Gross Margin | -151.47% |
| Operating Margin | -2020.04% |
| Net Margin | -2449.04% |
Related companies: BIAF · BIVI · BJDX · GLMD · HSCS · NDRA · SHPH
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of ISPC: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks